We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 43

Novopharm Limited v. Eli Lilly and Company (2010 FC 915)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection

Apotex v. Pfizer, motion to strike part of a defence pertaining to res judicata, sildenafil citrate, June 11, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

Apotex applied to impeach Pfizer's patent for Viagra and Pfizer defended alleging, in part, res judicata

Novopharm v. The Minister of Health, motion for a confidentiality order in a judicial review application of decision of Minister of Health, drug name confidential, May 26, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

The Minister decided that before a NOC could be issued to Novopharm, Novopharm must address a specific patent on the Patent Register

Counterfeiters face stiff penalties in Canada

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 10 2014

The Office of the United States Trade Representative ("USTR") publishes a report every few years called the Special 301 Report. In the report, the

Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998

Apotex v Syntex and Roche, dismissal of appeal concerning section 8 of PMNOC Regulations, naproxen, June 10, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

Apotex had sued Roche for damages pursuant to s. 8 of the PMNOC Regulations

Pfizer v. Novopharm, appeal of decision of prothonotary to deny Novopharm’s motion for confidentiality in PMNOC Regulations case, pregabalin, June 21, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

Novopharm served a NOA on Pfizer which it had unilaterally designated confidential

Janssen-Ortho v. Apotex, recusal by the judge, levofloxacin, June 14, 2010; motion to dismiss granted, levofloxacin, June 29, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

In a PMNOC case, Justice Shore granted an order of prohibition against Apotex in respect of its levofloxacin until patent expiry

Pfizer v Ratiopharm, PMNOC Regulations decision, sildenafil citrate, June 8, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

The Court dismissed an application for an order of prohibition under the PMNOC Regulations, wherein ratiopharm sought a generic version of the drug Revatio containing sildenafil citrate (the active ingredient in Viagra) until after the expiry of a Pfizer patent

Astrazeneca v. Apotex, PMNOC Regulations decision, esomeprazole, June 30, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 16 2010

The court dismissed AstraZeneca's application AstraZeneca for an order prohibiting the issuance of a Notice of Compliance ("NOC") to Apotex on the grounds that the allegation of invalidity was justified insofar as the assertions of lack of utilitysound prediction and obviousness, but not justified regarding an assertion of anticipation